GLP-1 agonists also protect the kidney

GLP-1 agonists also protect the kidney

0 Comments

Sydney – A new comprehensive analysis of the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on renal and cardiovascular outcomes shows they provide significant benefits to people with and without diabetes. As researchers led by